0REZ Stock Overview
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
AddLife AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 147.58 |
| 52 Week High | SEK 178.80 |
| 52 Week Low | SEK 95.10 |
| Beta | 1.48 |
| 1 Month Change | -16.11% |
| 3 Month Change | 6.48% |
| 1 Year Change | 41.34% |
| 3 Year Change | -44.35% |
| 5 Year Change | 156.58% |
| Change since IPO | 427.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0REZ | GB Life Sciences | GB Market | |
|---|---|---|---|
| 7D | -4.3% | -4.0% | -0.5% |
| 1Y | 41.3% | -31.4% | 8.5% |
Return vs Industry: 0REZ exceeded the UK Life Sciences industry which returned -31.4% over the past year.
Return vs Market: 0REZ exceeded the UK Market which returned 8.5% over the past year.
Price Volatility
| 0REZ volatility | |
|---|---|
| 0REZ Average Weekly Movement | 6.4% |
| Life Sciences Industry Average Movement | 7.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 10.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0REZ has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0REZ's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1906 | 2,256 | Fredrik Dalborg | www.add.life |
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments.
AddLife AB (publ) Fundamentals Summary
| 0REZ fundamental statistics | |
|---|---|
| Market cap | SEK 18.22b |
| Earnings (TTM) | SEK 252.00m |
| Revenue (TTM) | SEK 10.29b |
72.3x
P/E Ratio1.8x
P/S RatioIs 0REZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0REZ income statement (TTM) | |
|---|---|
| Revenue | SEK 10.29b |
| Cost of Revenue | SEK 6.43b |
| Gross Profit | SEK 3.86b |
| Other Expenses | SEK 3.61b |
| Earnings | SEK 252.00m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Apr 04, 2025
| Earnings per share (EPS) | 2.07 |
| Gross Margin | 37.52% |
| Net Profit Margin | 2.45% |
| Debt/Equity Ratio | 85.5% |
How did 0REZ perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield36%
Payout RatioDoes 0REZ pay a reliable dividends?
See 0REZ dividend history and benchmarks| AddLife dividend dates | |
|---|---|
| Ex Dividend Date | May 09 2025 |
| Dividend Pay Date | May 15 2025 |
| Days until Ex dividend | 53 days |
| Days until Dividend pay date | 59 days |
Does 0REZ pay a reliable dividends?
See 0REZ dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/16 11:35 |
| End of Day Share Price | 2025/03/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AddLife AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Karl Norén | Danske Bank |
| Gustav Berneblad | Nordea Markets |